Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Jeffrey Moy. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Jeffrey Moy har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:DXCM / DexCom, Inc. | EVP Operations | 34 784 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Jeffrey Moy. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Jeffrey Moy som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2020-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 577 | 34 784 | −6,90 | 398,30 | −1 026 424 | 13 854 537 | |
2020-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −1 003 | 37 361 | −2,61 | 398,30 | −399 497 | 14 880 961 | |
2020-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 6 967 | 38 364 | 22,19 | ||||
2020-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −6 967 | 19 684 | −26,14 | ||||
2020-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −5 956 | 31 397 | −15,95 | 265,43 | −1 580 877 | 8 333 580 | |
2020-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −166 | 37 353 | −0,44 | 250,19 | −41 532 | 9 345 377 | |
2020-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −81 | 37 519 | −0,22 | 245,44 | −19 880 | 9 208 555 | |
2020-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 12 568 | 37 600 | 50,21 | ||||
2020-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −12 568 | 26 651 | −32,05 | ||||
2020-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 8 811 | 39 219 | 28,98 | 0,00 | 9 | 39 | |
2020-03-03 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −362 | 25 032 | −1,43 | 278,10 | −100 672 | 6 961 399 |
2020-02-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −100 | 25 220 | −0,39 | 290,98 | −29 098 | 7 338 516 |
2020-02-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −200 | 25 320 | −0,78 | 289,84 | −57 968 | 7 338 749 |
2020-02-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 795 | 25 520 | −9,87 | 288,99 | −807 717 | 7 374 930 |
2020-02-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −400 | 28 315 | −1,39 | 287,41 | −114 965 | 8 138 085 |
2020-02-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −800 | 28 715 | −2,71 | 286,54 | −229 236 | 8 228 140 |
2020-02-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 694 | 29 515 | −5,43 | 284,23 | −481 480 | 8 388 945 |
2020-02-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −610 | 31 209 | −1,92 | 283,37 | −172 855 | 8 843 663 |
2020-02-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 4 461 | 31 819 | 16,31 | ||||
2020-02-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −4 461 | 30 408 | −12,79 | ||||
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −4 351 | 34 869 | −11,09 | 150,11 | −653 133 | 5 234 224 | |
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −250 | 39 220 | −0,63 | 145,37 | −36 341 | 5 701 223 | |
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −1 594 | 27 358 | −5,51 | 142,79 | −227 611 | 3 906 509 | |
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −5 001 | 28 952 | −14,73 | 142,79 | −714 104 | 4 134 120 | |
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −1 936 | 33 953 | −5,39 | 142,79 | −276 446 | 4 848 224 | |
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 10 031 | 35 889 | 38,79 | ||||
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 3 647 | 25 858 | 16,42 | ||||
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 5 500 | 22 211 | 32,91 | ||||
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −10 031 | 39 432 | −20,28 | ||||
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −3 647 | 49 463 | −6,87 | ||||
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −5 500 | 53 110 | −9,38 | ||||
2019-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 11 714 | 58 610 | 24,98 | 0,00 | 12 | 59 | |
2018-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 736 | 16 711 | −25,55 | 143,35 | −822 256 | 2 395 522 |
2018-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 17 386 | 22 447 | 343,53 | ||||
2018-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −17 386 | 46 534 | −27,20 | ||||
2018-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −2 762 | 63 920 | −4,14 | 143,76 | −397 052 | 9 188 832 | |
2018-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −1 832 | 66 682 | −2,67 | 143,76 | −263 360 | 9 585 884 | |
2018-08-03 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 831 | 5 061 | −53,53 | 94,13 | −548 872 | 476 392 |
2018-07-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −23 767 | 10 892 | −68,57 | 93,11 | −2 212 953 | 1 014 157 |
2018-07-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −26 205 | 34 659 | −43,06 | 92,26 | −2 417 741 | 3 197 729 |
2018-07-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −9 221 | 60 864 | −13,16 | 91,49 | −843 603 | 5 568 277 |
2018-06-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | −315 | 70 085 | −0,45 | ||||
2018-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 992 | 68 511 | −4,18 | 60,73 | −181 706 | 4 160 714 | |
2018-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 402 | 71 503 | −3,25 | 60,73 | −145 875 | 4 342 420 | |
2018-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −1 929 | 73 905 | −2,54 | 60,73 | −117 149 | 4 488 295 | |
2018-03-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 30 093 | 75 834 | 65,79 | 0,00 | 30 | 76 | |
2017-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 523 | 70 400 | −4,77 | 71,81 | −252 999 | 5 055 663 | |
2017-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 907 | 73 923 | −3,78 | 71,81 | −208 762 | 5 308 662 | |
2017-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 6 666 | 76 830 | 9,50 | 71,26 | 475 019 | 5 474 906 | |
2017-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 5 500 | 70 164 | 8,51 | 71,26 | 391 930 | 4 999 887 | |
2017-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −6 666 | 45 410 | −12,80 | 71,26 | −475 019 | 3 235 917 | |
2017-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −5 500 | 52 076 | −9,55 | 71,26 | −391 930 | 3 710 936 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −5 813 | 64 664 | −8,25 | 77,55 | −450 802 | 5 014 732 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 867 | 70 477 | −3,91 | 77,55 | −222 338 | 5 465 534 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 213 | 73 344 | −4,20 | 77,55 | −249 170 | 5 687 871 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 11 000 | 76 557 | 16,78 | 78,24 | 860 640 | 5 989 820 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 6 667 | 65 557 | 11,32 | 78,24 | 521 626 | 5 129 180 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 8 334 | 58 890 | 16,48 | 78,24 | 652 052 | 4 607 554 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −11 000 | 57 486 | −16,06 | 78,24 | −860 640 | 4 497 705 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −6 667 | 68 486 | −8,87 | 78,24 | −521 626 | 5 358 345 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −8 334 | 75 153 | −9,98 | 78,24 | −652 052 | 5 879 971 | |
2017-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 21 883 | 83 487 | 35,52 | 0,00 | 22 | 83 | |
2016-09-22 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | −290 | 50 556 | −0,57 | ||||
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 556 | 50 846 | −6,54 | 93,72 | −333 279 | 4 765 435 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 445 | 54 402 | −7,55 | 93,72 | −416 597 | 5 098 697 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 6 666 | 58 847 | 12,77 | 65,80 | 438 623 | 3 872 133 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 8 333 | 52 181 | 19,00 | 95,80 | 798 301 | 4 998 940 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −6 666 | 61 334 | −9,80 | 95,80 | −638 603 | 5 875 797 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −8 333 | 68 000 | −10,92 | 95,80 | −798 301 | 6 514 400 | |
2016-08-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 12 599 | −44,25 | 93,00 | −930 000 | 1 171 707 |
2016-08-02 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 22 599 | −18,12 | 91,00 | −455 000 | 2 056 509 |
2016-07-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 27 599 | −26,60 | 88,48 | −884 800 | 2 441 960 |
2016-07-21 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 37 599 | −11,74 | 85,00 | −425 000 | 3 195 915 |
2016-07-21 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 843 | 76 333 | −9,32 | 83,00 | −650 969 | 6 335 639 |
2016-07-01 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 557 | 50 442 | −8,29 | 80,00 | −364 560 | 4 035 360 |
2016-06-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 209 | 54 999 | −11,59 | 77,00 | −555 093 | 4 234 923 |
2016-06-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −6 910 | 62 208 | −10,00 | 74,00 | −511 340 | 4 603 392 |
2016-06-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −6 866 | 69 118 | −9,04 | 71,00 | −487 486 | 4 907 378 |
2016-03-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 430 | 75 984 | −5,51 | 63,96 | −283 348 | 4 860 020 | |
2016-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 8 334 | 80 414 | 11,56 | 65,15 | 542 960 | 5 238 972 | |
2016-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −8 334 | 76 333 | −9,84 | 65,15 | −542 960 | 4 973 095 | |
2016-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 532 | 72 080 | −8,31 | 63,18 | −412 692 | 4 554 014 | |
2016-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 321 | 78 612 | −4,05 | 63,18 | −209 821 | 4 966 706 | |
2016-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 13 334 | 81 933 | 19,44 | 66,10 | 881 377 | 5 415 771 | |
2016-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 8 333 | 68 599 | 13,83 | 66,10 | 550 811 | 4 534 394 | |
2016-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −13 334 | 84 667 | −13,61 | 66,10 | −881 377 | 5 596 489 | |
2016-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −8 333 | 98 001 | −7,84 | 66,10 | −550 811 | 6 477 866 | |
2016-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 33 000 | 106 334 | 45,00 | 0,00 | 33 | 106 | |
2015-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 416 | 59 982 | −6,86 | 95,93 | −423 638 | 5 754 229 | |
2015-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 8 333 | 64 398 | 14,86 | 97,41 | 811 718 | 6 273 009 | |
2015-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −8 333 | 73 334 | −10,20 | 97,41 | −811 718 | 7 143 465 | |
2015-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 404 | 56 065 | −7,28 | 90,90 | −400 317 | 5 096 224 | |
2015-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 8 333 | 60 469 | 15,98 | 91,05 | 758 720 | 5 505 702 | |
2015-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −8 333 | 81 667 | −9,26 | 91,05 | −758 720 | 7 435 780 | |
2015-09-03 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −8 881 | 52 136 | −14,55 | 90,61 | −804 683 | 4 723 902 |
2015-08-21 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −6 029 | 61 017 | −8,99 | 97,49 | −587 773 | 5 948 602 |
2015-08-06 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 276 | 67 046 | −7,30 | 85,18 | −449 396 | 5 710 811 |
2015-07-22 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 786 | 72 322 | −4,97 | 83,48 | −316 055 | 6 037 441 |
2015-07-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 76 108 | −6,16 | 79,32 | −396 616 | 6 037 138 |
2015-06-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 154 | 81 108 | −5,97 | 77,54 | −399 630 | 6 288 936 |
2015-06-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −9 869 | 86 262 | −10,27 | 73,00 | −720 437 | 6 297 126 | |
2015-06-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 96 131 | −4,94 | 70,63 | −353 132 | 6 789 386 |
2015-05-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −16 791 | 101 131 | −14,24 | 70,00 | −1 175 370 | 7 079 170 | |
2015-05-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 117 922 | −4,07 | 68,24 | −341 212 | 8 047 292 |
2015-05-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −15 586 | 122 922 | −11,25 | 69,20 | −1 078 551 | 8 506 202 | |
2015-05-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 138 508 | −3,48 | 66,58 | −332 876 | 9 221 198 |
2015-05-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −15 303 | 143 508 | −9,64 | 68,25 | −1 044 494 | 9 795 024 | |
2015-04-29 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 158 811 | −3,05 | 67,55 | −337 750 | 10 727 699 |
2015-04-29 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | 69,27 | −346 368 | ||
2015-04-29 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 90 000 | −5,26 | 69,27 | −346 368 | 6 234 624 |
2015-04-29 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 95 000 | 5,56 | 9,36 | 46 800 | 889 200 | |
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 163 811 | −2,96 | 67,32 | −336 582 | 11 027 183 |
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −5 000 | 5 000 | −50,00 | 67,78 | −338 904 | 338 904 | |
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 90 000 | −5,26 | 67,78 | −338 904 | 6 100 263 |
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 95 000 | 5,56 | 9,36 | 46 800 | 889 200 | |
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −1 956 | 0 | −100,00 | 65,76 | −128 631 | ||
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −5 000 | 10 000 | −33,33 | 65,78 | −328 889 | 657 778 | |
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −3 000 | 15 000 | −16,67 | 65,76 | −197 287 | 986 433 | |
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −810 | 0 | −100,00 | 65,76 | −53 267 | ||
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 90 000 | −5,26 | 65,78 | −328 889 | 5 920 002 |
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 95 000 | 5,56 | 9,36 | 46 800 | 889 200 | |
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 000 | 90 000 | −3,23 | 65,76 | −197 287 | 5 918 598 |
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 3 000 | 93 000 | 3,33 | 9,36 | 28 080 | 870 480 | |
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −810 | 90 000 | −0,89 | 65,76 | −53 267 | 5 918 598 |
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 810 | 90 810 | 0,90 | 7,63 | 6 180 | 692 880 | |
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 956 | 90 000 | −2,13 | 65,76 | −128 631 | 5 918 598 |
2015-04-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 1 956 | 91 956 | 2,17 | 9,80 | 19 169 | 901 169 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | −450 | 168 811 | −0,27 | ||||
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 448 | 169 261 | −2,56 | 58,58 | −260 547 | 9 914 666 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 8 333 | 173 709 | 5,04 | 59,91 | 499 230 | 10 406 906 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −8 824 | 165 376 | −5,07 | 58,74 | −518 324 | 9 714 219 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 861 | 174 200 | −2,17 | 58,74 | −226 796 | 10 232 543 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −8 333 | 90 000 | −8,47 | 59,91 | −499 230 | 5 391 900 | |
2015-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 16 667 | 178 061 | 10,33 | 59,59 | 993 187 | 10 610 655 | |
2015-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 7 292 | 161 394 | 4,73 | 59,59 | 434 530 | 9 617 468 | |
2015-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −16 667 | 98 333 | −14,49 | 59,59 | −993 187 | 5 859 663 | |
2015-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −7 292 | 115 000 | −5,96 | 59,59 | −434 530 | 6 852 850 | |
2015-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 40 000 | 122 292 | 48,61 | 0,00 | 40 | 122 | |
2015-03-04 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −5 000 | 1 956 | −71,88 | 60,33 | −301 650 | 118 005 | |
2015-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 82 292 | −5,73 | 60,33 | −301 650 | 4 964 668 |
2015-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 87 292 | 6,08 | 9,80 | 49 000 | 855 462 | |
2015-02-19 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 044 | 0 | −100,00 | 62,11 | −313 291 | ||
2015-02-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 044 | 82 292 | −5,78 | 62,11 | −313 291 | 5 111 288 |
2015-02-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 044 | 87 336 | 6,13 | 9,80 | 49 431 | 855 893 | |
2015-02-04 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 5 044 | −49,78 | 60,68 | −303 425 | 306 095 | |
2015-02-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 82 964 | −5,68 | 60,68 | −303 425 | 5 034 670 |
2015-02-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 87 964 | 6,03 | 9,80 | 49 000 | 862 047 | |
2015-01-22 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 10 044 | −33,24 | 57,58 | −287 906 | 578 346 | |
2015-01-22 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 82 292 | −5,73 | 57,58 | −287 906 | 4 738 472 |
2015-01-22 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 87 292 | 6,08 | 9,80 | 49 000 | 855 462 | |
2015-01-07 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 15 044 | −24,95 | 55,27 | −276 368 | 831 536 | |
2015-01-07 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 82 292 | −5,73 | 55,27 | −276 368 | 4 548 575 |
2015-01-07 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 87 292 | 6,08 | 9,80 | 49 000 | 855 462 | |
2014-11-13 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 000 | 20 044 | −16,64 | 53,00 | −212 000 | 1 062 332 | |
2014-11-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −4 000 | 82 292 | −4,64 | 53,00 | −212 000 | 4 361 476 | |
2014-11-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 000 | 86 292 | 4,86 | 9,80 | 39 200 | 845 662 | |
2014-09-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | −650 | 153 430 | −0,42 | ||||
2014-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 8 333 | 154 080 | 5,72 | 43,36 | 361 339 | 6 681 279 | |
2014-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 404 | 145 747 | −2,93 | 43,36 | −190 968 | 6 319 940 | |
2014-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 7 291 | 150 151 | 5,10 | 43,23 | 315 196 | 6 491 148 | |
2014-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 802 | 142 860 | −2,59 | 43,23 | −164 368 | 6 176 138 | |
2014-08-28 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 24 044 | −29,37 | 45,50 | −455 000 | 1 094 002 | |
2014-08-28 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 663 | 0 | −100,00 | 45,00 | −299 835 | ||
2014-08-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −6 663 | 97 916 | −6,37 | 45,00 | −299 835 | 4 406 220 | |
2014-08-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 6 663 | 104 579 | 6,80 | 6,33 | 42 177 | 661 985 | |
2014-08-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −10 000 | 97 916 | −9,27 | 45,50 | −455 000 | 4 455 178 | |
2014-08-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 107 916 | 10,21 | 9,80 | 98 000 | 1 057 577 | |
2014-04-29 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −2 000 | 18 000 | −10,00 | 33,38 | −66 760 | 600 840 | |
2014-04-29 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −3 097 | 810 | −79,27 | 33,38 | −103 378 | 27 038 | |
2014-04-29 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 2 000 | 146 662 | 1,38 | 9,36 | 18 720 | 1 372 756 | |
2014-04-29 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 3 097 | 144 662 | 2,19 | 7,63 | 23 630 | 1 103 771 | |
2014-04-09 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −6 463 | 0 | −100,00 | 35,68 | −230 600 | ||
2014-04-09 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −1 | 0 | −100,00 | 35,68 | −36 | ||
2014-04-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 6 463 | 141 565 | 4,78 | 6,33 | 40 911 | 896 106 | |
2014-04-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 1 | 135 102 | 0,00 | 3,19 | 3 | 430 975 | |
2014-03-31 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −15 000 | 6 463 | −69,89 | 40,50 | −607 500 | 261 752 | |
2014-03-31 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 15 000 | 233 017 | 6,88 | 6,33 | 94 950 | 1 474 998 | |
2014-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −8 808 | 218 017 | −3,88 | 45,22 | −398 312 | 9 859 078 | |
2014-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −10 660 | 226 825 | −4,49 | 46,10 | −491 441 | 10 456 950 | |
2014-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 50 000 | 237 485 | 26,67 | 0,00 | 50 | 237 | |
2014-03-06 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 6 663 | −42,87 | 47,50 | −237 500 | 316 492 | |
2014-03-06 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −5 000 | 187 485 | −2,60 | 47,50 | −237 500 | 8 905 538 | |
2014-03-06 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 192 485 | 2,67 | 6,33 | 31 650 | 1 218 430 | |
2014-03-06 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 11 663 | −30,01 | 47,10 | −235 500 | 549 327 | |
2014-03-06 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −5 000 | 187 485 | −2,60 | 47,10 | −235 500 | 8 830 544 | |
2014-03-06 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 192 485 | 2,67 | 6,33 | 31 650 | 1 218 430 | |
2014-03-04 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 500 | 16 663 | −13,05 | 46,45 | −116 125 | 773 996 | |
2014-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −2 500 | 187 485 | −1,32 | 46,45 | −116 125 | 8 708 678 | |
2014-03-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 2 500 | 189 985 | 1,33 | 6,33 | 15 825 | 1 202 605 | |
2014-02-28 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 500 | 19 163 | −11,54 | 45,97 | −114 920 | 880 887 | |
2014-02-28 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 750 | 0 | −100,00 | 45,48 | −397 950 | ||
2014-02-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −8 750 | 187 485 | −4,46 | 45,48 | −397 950 | 8 526 818 | |
2014-02-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 8 750 | 196 235 | 4,67 | 3,19 | 27 912 | 625 990 | |
2014-02-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −2 500 | 187 485 | −1,32 | 45,97 | −114 920 | 8 618 329 | |
2014-02-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 2 500 | 189 985 | 1,33 | 6,33 | 15 825 | 1 202 605 | |
2013-09-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −8 023 | 186 364 | −4,13 | 26,89 | −215 734 | 5 011 216 | |
2013-05-17 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 39 999 | −11,11 | 19,97 | −99 872 | 798 960 | |
2013-05-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −5 000 | 194 248 | −2,51 | 19,97 | −99 872 | 3 880 007 | |
2013-05-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 199 248 | 2,57 | 3,19 | 15 950 | 635 601 | |
2013-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −10 423 | 194 248 | −5,09 | 15,69 | −163 537 | 3 047 751 | |
2013-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 50 000 | 204 671 | 32,33 | 0,00 | 50 | 205 | |
2012-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 687 | 152 558 | −2,98 | 13,68 | −64 102 | 2 086 475 | |
2012-09-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −10 000 | 157 245 | −5,98 | 13,30 | −133 000 | 2 091 358 | |
2012-08-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −21 249 | 167 245 | −11,27 | 12,80 | −271 987 | 2 140 736 | |
2012-03-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 833 | 188 494 | −1,99 | 10,26 | −39 320 | 1 933 628 | |
2012-03-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −5 615 | 192 327 | −2,84 | 10,26 | −57 600 | 1 972 948 | |
2012-03-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 43 750 | 197 942 | 28,37 | 0,00 | 44 | 198 |